Media stories about Midland Exploration (NYSE:MD) have been trending somewhat positive recently, according to Accern. The research firm ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Midland Exploration earned a daily sentiment score of 0.11 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.479227446673 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Here are some of the news headlines that may have effected Accern Sentiment’s rankings:

Shares of Midland Exploration (NYSE:MD) opened at C$44.47 on Friday. Midland Exploration has a fifty-two week low of C$40.56 and a fifty-two week high of C$72.13.

Midland Exploration (NYSE:MD) last released its quarterly earnings results on Wednesday, November 1st. The company reported C$0.87 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of C$0.87. The business had revenue of C$868.95 million during the quarter, compared to analysts’ expectations of C$864.78 million. Midland Exploration had a return on equity of 9.12% and a net margin of 7.56%. The firm’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same period last year, the firm posted $1.09 EPS.

MD has been the subject of a number of analyst reports. BMO Capital Markets initiated coverage on Midland Exploration in a research note on Monday, October 16th. They issued a “market perform” rating and a $46.00 price target for the company. Zacks Investment Research upgraded Midland Exploration from a “sell” rating to a “hold” rating in a research note on Wednesday, October 11th. Robert W. Baird restated a “hold” rating and issued a $47.00 price target on shares of Midland Exploration in a research note on Sunday, September 3rd. BidaskClub downgraded Midland Exploration from a “sell” rating to a “strong sell” rating in a research note on Friday, August 4th. Finally, KeyCorp set a $51.00 target price on Midland Exploration and gave the stock a “buy” rating in a research note on Wednesday, November 1st. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of C$54.50.

ILLEGAL ACTIVITY WARNING: This story was published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this story on another site, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this story can be viewed at https://theolympiareport.com/2017/11/12/midland-exploration-md-earning-somewhat-positive-media-coverage-accern-reports.html.

In related news, insider John C. Pepia sold 3,000 shares of Midland Exploration stock in a transaction that occurred on Tuesday, September 12th. The stock was sold at an average price of C$42.85, for a total transaction of C$128,550.00. Following the completion of the sale, the insider now directly owns 35,569 shares of the company’s stock, valued at approximately C$1,524,131.65. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Cesar L. Alvarez sold 10,668 shares of Midland Exploration stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of C$42.59, for a total value of C$454,350.12. Following the sale, the director now directly owns 44,215 shares of the company’s stock, valued at C$1,883,116.85. The disclosure for this sale can be found here.

Midland Exploration Company Profile

MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company’s national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.

Insider Buying and Selling by Quarter for Midland Exploration (NYSE:MD)

Receive News & Ratings for Midland Exploration Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Midland Exploration Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.